Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses
Authors:ID Laurie, Steven (Author)
ID Steyaert, Wouter (Author)
ID De Boer, Elke (Author)
ID Polavarapu, Kiran (Author)
ID Schuermans, Nika (Author)
ID Sommer, Anna K. (Author)
ID Demidov, German (Author)
ID Maver, Aleš (Author)
ID Peterlin, Borut (Author), et al.
Files:.pdf PDF - Presentation file, download (10,60 MB)
MD5: C738E209A6CB2FCFF76842279B769329
 
URL URL - Source URL, visit https://www.nature.com/articles/s41591-024-03420-w
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Genetic diagnosis of rare diseases requires accurate identification and interpretation of genomic variants. Clinical and molecular scientists from 37 expert centers across Europe created the Solve-Rare Diseases Consortium (Solve-RD) resource, encompassing clinical, pedigree and genomic rare-disease data (94.5% exomes, 5.5% genomes), and performed systematic reanalysis for 6,447 individuals (3,592 male, 2,855 female) with previously undiagnosed rare diseases from 6,004 families. We established a collaborative, two-level expert review infrastructure that allowed a genetic diagnosis in 506 (8.4%) families. Of 552 disease-causing variants identified, 464 (84.1%) were single-nucleotide variants or short insertions/deletions. These variants were either located in recently published novel disease genes (n = 67), recently reclassified in ClinVar (n = 187) or reclassified by consensus expert decision within Solve-RD (n = 210). Bespoke bioinformatics analyses identified the remaining 15.9% of causative variants (n = 88). Ad hoc expert review, parallel to the systematic reanalysis, diagnosed 249 (4.1%) additional families for an overall diagnostic yield of 12.6%. The infrastructure and collaborative networks set up by Solve-RD can serve as a blueprint for future further scalable international efforts. The resource is open to the global rare-disease community, allowing phenotype, variant and gene queries, as well as genome-wide discoveries.
Keywords:rare diseases, identification, interpretation, genetic diagnosis, genomic variants
Publication status:Published
Publication version:Version of Record
Year of publishing:2025
Number of pages:str. 478–489
Numbering:Vol. 31
PID:20.500.12556/DiRROS-24134 New window
UDC:61:575
ISSN on article:1546-170X
DOI:10.1038/s41591-024-03420-w New window
COBISS.SI-ID:239892227 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 19. 6. 2025;
Publication date in DiRROS:17.11.2025
Views:197
Downloads:104
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Nature medicine
Shortened title:Nat Med (Online)
Publisher:Nature Publishing Group
ISSN:1546-170X
COBISS.SI-ID:2928916 New window

Document is financed by a project

Funder:EC - European Commission
Project number:779257
Name:Solving the unsolved Rare Diseases
Acronym:Solve-RD

Funder:EC - European Commission
Project number:305444
Name:RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research
Acronym:RD-CONNECT

Funder:EC - European Commission
Project number:825575
Name:European Joint Programme on Rare Diseases
Acronym:EJP RD

Funder:EC - European Commission
Project number:676559
Name:ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences.
Acronym:ELIXIR-EXCELERATE

Funder:EC - European Commission
Project number:101080249
Name:Accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology
Acronym:SIMPATHIC

Funder:EC - European Commission
Project number:101080997
Name:Reconstruction and Computational Modelling for Inherited Metabolic Diseases
Acronym:Recon4IMD

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Back